Literature DB >> 6870484

LSD psychosis or LSD-induced schizophrenia? A multimethod inquiry.

M M Vardy, S R Kay.   

Abstract

We studied whether patients hospitalized for LSD psychosis are clinically separable from acute schizophrenics. The family histories, manifest symptoms, premorbid adjustment, and profiles on an extensive test battery were analyzed for 52 LSD psychotics and 29 matched first-break schizophrenics. The LSD patients did not differ from schizophrenics in incidence of psychosis or suicide among the parents. However, the rate of parental alcoholism for LSD psychotics far exceeded that for schizophrenics and the general population. The two groups were distinguished on some clinical features but were equivalent in premorbid adjustment, on most cognitive measures when initially hospitalized or reassessed three to five years later, and in number of subsequent rehospitalizations. Thus, in most respects the LSD psychotics were fundamentally similar to schizophrenics in geneaology, phenomenology, and course of illness. The findings supported a model of LSD psychosis as a drug-induced schizophreniform reaction in persons vulnerable to both substance abuse and psychosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870484     DOI: 10.1001/archpsyc.1983.01790070067008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  10 in total

Review 1.  Drug models of schizophrenia.

Authors:  Hannah Steeds; Robin L Carhart-Harris; James M Stone
Journal:  Ther Adv Psychopharmacol       Date:  2015-02

2.  Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Naruya Saitou; Takashi Kitano; Bryan J Mowry; Raymond R Crowe; Jeremy M Silverman; Douglas F Levinson; Pablo V Gejman
Journal:  Am J Hum Genet       Date:  2004-08-24       Impact factor: 11.025

Review 3.  Prevalence of alcohol and drug abuse in schizophrenic inpatients.

Authors:  M Soyka; M Albus; N Kathmann; A Finelli; S Hofstetter; R Holzbach; B Immler; P Sand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

4.  Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia.

Authors:  Natalia V Malkova; Joseph J Gallagher; Collin Z Yu; Russell E Jacobs; Paul H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

5.  Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.

Authors:  Alessandra Paparelli; Marta Di Forti; Paul D Morrison; Robin M Murray
Journal:  Front Behav Neurosci       Date:  2011-01-17       Impact factor: 3.558

Review 6.  d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.

Authors:  Danilo De Gregorio; Stefano Comai; Luca Posa; Gabriella Gobbi
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

7.  Altered network hub connectivity after acute LSD administration.

Authors:  Felix Müller; Patrick C Dolder; André Schmidt; Matthias E Liechti; Stefan Borgwardt
Journal:  Neuroimage Clin       Date:  2018-03-07       Impact factor: 4.881

8.  Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences.

Authors:  Petter Grahl Johnstad
Journal:  Nordisk Alkohol Nark       Date:  2020-10-20

Review 9.  Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

Authors:  Athanasios Markopoulos; Antonio Inserra; Danilo De Gregorio; Gabriella Gobbi
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

10.  Psychedelics and mental health: a population study.

Authors:  Teri S Krebs; Pål-Ørjan Johansen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.